Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
life sciences
nash
7
×
national blog main
texas blog main
7
×
texas top stories
national top stories
new york blog main
raleigh-durham blog main
acquisition
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
buyout
celgene
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical devices
national
new york top stories
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
acelity
allergan
apax partners
biotech
botox
breast implant
breast reconstruction
bristol-myers squibb
chase pharmaceutical corp.
What
bio
roundup
acelity
antonio
drug
san
biogen
company
ipo
known
news
products
week
wound
years
ace
acquired
adu
aducanumab
advanced
allogene
alnylam’s
alzheimer’s
amyloid
angst
approval
approved
bagged
bandages
beats
bff
bids
billion
billions
biogen’s
brammer
business
cancer
complicated
conference
Language
Current search:
nash
×
photo
×
" texas blog main "
×
@xconomy.com
5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com
5 years ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More